These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 332343)

  • 1. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common human melanoma membrane antigens detected by mixed hemadsorption microassay with serum from a patient undergoing immunotherapy with autologous tumor cells.
    Liao SK; Leong SP; Sutherland CM; Dent PB; Kwong PC; Krementz ET
    Cancer Res; 1978 Dec; 38(12):4395-400. PubMed ID: 82477
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in distribution of human malignant melanoma membrane antigens in the presence of human antibody by immunofluorescence.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Jan; 37(1):293-8. PubMed ID: 318607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serological analysis of melanoma patients receiving autologous melanoma cell vaccines].
    Watanabe T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):261-72. PubMed ID: 6881976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine.
    Bystryn JC; Henn M; Li J; Shroba S
    Cancer Res; 1992 Nov; 52(21):5948-53. PubMed ID: 1382848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-induced movement of common melanoma membrane antigens on the surface of unfixed human melanoma cells.
    Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Cesare JF; Krementz ET
    Cancer Res; 1979 Jun; 39(6 Pt 1):2125-31. PubMed ID: 376115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologically detectable MHC and tumor-associated antigens on B16 melanoma variants and humoral immunity in mice bearing these tumors.
    Baniyash M; Smorodinsky NI; Yaakubovicz M; Witz IP
    J Immunol; 1982 Sep; 129(3):1318-23. PubMed ID: 7108209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigens on human tumor cells assayed by complement fixation with allogeneic sera.
    Gupta RK; Irie RF; Morton DL
    Cancer Res; 1978 Aug; 38(8):2573-80. PubMed ID: 78763
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vaccine therapy of malignant melanoma. II. Serological evaluation of the immune responses to the injection using allogeneic melanoma cell vaccine].
    Takeyama H; Watanabe T; Livingston PO
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1624-33. PubMed ID: 6870307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells.
    Savage HE; Rossen RD; Hersh EM; Freedman RS; Bowen JM; Plager C
    Cancer Res; 1986 Apr; 46(4 Pt 2):2127-33. PubMed ID: 3948184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature of immune complexes in human cancer sera.
    Theofilopoulos AN; Andrews BS; Urist MM; Morton DL; Dixon FJ
    J Immunol; 1977 Aug; 119(2):657-63. PubMed ID: 886189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates.
    Berthier-Vergnes O; Portoukalian J; Lefthériotis E; Doré JF
    Cancer Res; 1994 May; 54(9):2433-9. PubMed ID: 8162593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological studies on malignant melanomas of man.
    Romsdahl MM; Cox IS
    Yale J Biol Med; 1973 Dec; 46(5):693-701. PubMed ID: 4205125
    [No Abstract]   [Full Text] [Related]  

  • 15. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
    Kirkwood JM; Vlock DR
    Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.
    Imai K; Ferrone S
    Cancer Res; 1980 Jul; 40(7):2252-6. PubMed ID: 6966965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated antigens in human malignant melanoma.
    Lewis MG; Avis PJ; Phillips TM; Sheikh KM
    Yale J Biol Med; 1973 Dec; 46(5):661-8. PubMed ID: 4591789
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of human melanoma antigens in cell-free supernatants.
    Leong SP; Cooperband SR; Sutherland CM; Krementz ET; Deckers PJ
    J Surg Res; 1978 Apr; 24(4):245-52. PubMed ID: 347171
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen.
    Jones PC; Sze LL; Liu PY; Morton DL; Irie RF
    J Natl Cancer Inst; 1981 Feb; 66(2):249-54. PubMed ID: 6935475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development in the immunotherapy of malignant melanoma].
    Tritsch H
    Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.